Navigation Links
Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
Date:11/12/2008

ive adults (those who have never taken HIV medication

before).

- 23 October 2008 - Darunavir received a positive opinion from the

European Medicines Agency's (EMEA) Committee for Medicinal Products for

Human Use (CHMP) to extend the drug's indication to treat human

immunodeficiency virus (HIV-1) infection to include

treatment-experienced adult patients. Darunavir, coadministered with low

dose ritonavir, is currently indicated for the treatment of HIV-1 in

combination with other antiretroviral medicines in highly pre-treated

adult patients who failed more than one regimen containing a protease

inhibitor.

Tibotec Data at ICAAC and HIV9 Data from multiple studies examining the use of darunavir in patients with varying levels of treatment experience were presented at ICAAC and will be presented at HIV9. Highlights include:

- A new analysis of ARTEMIS (AntiRetroviral Therapy with TMC114 Examined

In Naive Subjects), a randomised, controlled, open-label Phase III trial

that compares the 96-week efficacy and safety of darunavir/ritonavir

with lopinavir/ritonavir in treatment-naive adults. ARTEMIS is the first

study to examine darunavir/ritonavir in a once-daily dose in

treatment-naive patients with HIV. These data were presented at ICAAC on

26 October.

- A new analysis of TITAN (TMC114/r In Treatment-experienced patients

Naive to lopinavir), a randomised, controlled, open-label Phase III

study that compares the 96-week efficacy and safety of

darunavir/ritonavir with lopinavir/ritonavir in treatment-experienced,

lopinavir-naive patients. These data will be presented at HIV9 on 13

November.

The ARTEMIS and TITAN studies are ongoing. Darunavir and etravirine were developed by Tibotec Pharmaceuticals, Cork, Ireland. Tibotec, a division of Janssen-Cilag, is responsible for market
'/>"/>

SOURCE Tibotec Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
2. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
3. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
4. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
7. Inhaled Nitric Oxide Data Presented at European Academy of Pediatrics Meeting
8. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
9. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
10. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
11. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 STAAR Surgical Company (NASDAQ: ... of minimally invasive ophthalmic products, today announced that it ... the Company,s recent financial results and business developments with ... present at the 38 th Annual Deutsche Bank ... at the Westin Waterfront Hotel on Wednesday, May 29, ...
(Date:5/20/2013)... , May 21, 2013 ... Assembly, where world,s health ministers gather to address the ... Mental and neurological disorders (MNDs) affect 700 million ... non-communicable disease (NCD) burden ,Do You Mind?, ... the role each can play to collectively address MNDs ...
(Date:5/20/2013)... GLENWOOD, Ill. , May 20, 2013 ... leader in personal and environmental radiation measurement and monitoring, ... accessories, announced today that its Board of Directors declared, ... quarterly cash dividend of $0.55 per share for the ... paid on July 3, 2013, to shareholders of record ...
Breaking Medicine Technology:STAAR Surgical To Present At Upcoming Investor Conferences 2Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Landauer, Inc. Declares Regular Cash Dividend 2
... CHAPEL HILL, N.C., July 22, 2011 The oncology ... new pharmaceutical product investment and launches as next generation ... more new targeted oncology products finding success, organizations in ... that is pushing them to rethink the factors that ...
... ST. LOUIS, July 22, 2011 United Seating & ... has finalized a transaction with Central Kentucky Mobility (CKM) to ... will continue services for Lexington, Louisville, as well as central, ... Kentucky Mobility,s rehab team strengthens our position within a core ...
Cached Medicine Technology:Success Factors and Failure Points for Oncology New Product Launches 2
(Date:5/21/2013)... May 21, 2013 The Special Olympics Missouri ... coaches from across the state to Columbia. This state-level event ... University of Missouri and Columbia College, and at Hickman High ... Summer Games officially kick off at 7:30 p.m. Friday, May ... a Go Wild! theme, the Parade of Athletes, the culmination ...
(Date:5/21/2013)... California (PRWEB) May 21, 2013 ... individuals who are grieving to remember and honor a ... Evening of Remembrance Memorial Service, Sunday, June 2, 2013, ... Skyline Boulevard, San Mateo, CA 94402. , The ... and includes a short program with music, readings and ...
(Date:5/21/2013)... 21, 2013 Puroast® Low Acid Coffee ... as its Chairman of the Board. , ... Johnson & Johnson during his more than 30-year career ... Executive Committee, Worldwide Chairman of Consumer Pharmaceuticals & Nutritionals ... helped to develop and build the market for such ...
(Date:5/21/2013)... Not all treatments are effective when ... Personality Disorder (BPD) and addiction. Dialectical Behavior Therapy (DBT) ... for the treatment of both BPD and substance abuse. ... clinical director of Clearview Women’s Center for Borderline ... attendees of the West Coast Symposium on Addictive Disorders ...
(Date:5/21/2013)... Journal of the Pediatric Infectious Diseases Society ... which includes a consensus statement of the global ... establishes standardized definitions, measurements, and other key attributes ... first step as the group of international stakeholders ... resources that can improve children,s access to prompt ...
Breaking Medicine News(10 mins):Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2Health News:Former Johnson & Johnson Executive Brian Perkins Named Chairman of Puroast® Coffee 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 2Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 3
... to fund multiple sclerosis researchCHICAGO, April 6 The ... support for MS education and awareness by purchasing the ... March 4, 2009, the Lottery released "Dash! For Cash" ... For Cash" is the second instant game created to ...
... decision by the Centers for Medicare and Medicaid Services ... scans in the initial treatment strategy of patients with ... compelling clinical evidence of the effectiveness of PET for ... known as the National Oncologic PET Registry (NOPR). ...
... hopes for stem cell therapy, major structural and cultural changes ... in the UK. Currently the chances of getting effective treatments ... industry is at serious risk of ,market failure,. , These ... and adoption of stem cell therapy carried out by researchers ...
... Americans free and unique fitness tools to help reduce stress ... is a fact of life. However, with the declining economy ... stressed than ever and some are looking for solutions on ... honor of Stress Awareness Month, is offering people free and ...
... or fiber and other beneficial nutrientsGLENDALE, Calif., April 6 ... to benefit children during different stages of their growth ... Juice Immunity are fruit juice beverages made with ... filtered water to naturally lower the sugar and calorie ...
... Rating Based on Quality Accounting and ManagementFRANKLIN LAKES, ... wondering about the safety of their savings, Forbes ... MHS ) as one of "The 100 Most Trustworthy ... upon Audit Integrity,s ranking of corporate accounting and management ...
Cached Medicine News:Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 2Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 3Health News:SNM calls CMS PET scan decision a major benefit for cancer patients 2Health News:SNM calls CMS PET scan decision a major benefit for cancer patients 3Health News:Stem cell innovation at risk 2Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 2Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 3Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 4Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 5Health News:From Early Brain Development to Digestive Health, New Juicy Juice Beverages Aid Children Through Different Stages of Growth and Development 2Health News:From Early Brain Development to Digestive Health, New Juicy Juice Beverages Aid Children Through Different Stages of Growth and Development 3Health News:From Early Brain Development to Digestive Health, New Juicy Juice Beverages Aid Children Through Different Stages of Growth and Development 4Health News:Forbes Counts Medco As One of The 'Most Trustworthy Companies' 2Health News:Forbes Counts Medco As One of The 'Most Trustworthy Companies' 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Select is ... automated microbial detection system that ... and mycobacteria culturing. This system ... management or laboratory information system ...
Medicine Products: